0      0

To Constrict or to Dilate, That Is the Question: Vasoactive Agents

‐ Sep 21, 2013 3:15pm

Vasoactive agents, whether resulting in dilation or constriction of the blood vessels, can cause issues in acute, chronic, CKD, and transplant patients. This session explores these agents, the settings in which they are used, the pharmacokinetic properties, and the implications for practice.

Contact hours available until 9/22/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Conflict of Interest Disclosure:
Speaker(s) have no disclosures to declare.

Conference Committee Disclosures:
Dawn Koonkongsatian – Employee, Fresenius Medical Care
Kristin Larson – Employee, NxStage Medical
Denise Murcek – Employee, Fresenius Medical Care
Beth St. John - Employee, Fresenius Medical Care
Lucy Todd – Employee, Baxter Healthcare
Kyra Trappett – Employee, DaVita

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

  • Describe the indications for vasoactive agents in the inpatient and outpatient settings.
  • Identify the different classifications of vasoactive agents.
  • Discuss the impact of vasoactive agents in dialysis treatments.


You must be logged in and own this session in order to post comments.